MAPT and Parkinson disease: Moreover, the lack of significant hippocampal atrophy and memory dysfunctions in our LBDs-Aβ+ patients, well supports data from a recent neuropathological study showing that tau pathology but not Aβ42 levels correlates with hippocampal volume and general cognitive status in non-demented Parkinson’s disease.79